neurohoogl.blogg.se - Snapgene p2a

#Snapgene p2a pdf#

238000002560 therapeutic procedure Methods 0.000 claims abstract description 19.239000008194 pharmaceutical composition Substances 0.000 claims abstract description 19.

102100002607 TIMP1 Human genes 0.000 claims abstract description 46.

201000011510 cancer Diseases 0.000 claims abstract description 92.

108060006632 Protein-arginine deiminases Proteins 0.000 title claims abstract description 46.

102000001235 Protein-arginine deiminases Human genes 0.000 title claims abstract description 46.

230000000174 oncolytic Effects 0.000 title claims abstract description 88.

Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Targovax ASA filed Critical Targovax ASA Priority to EP19169841.4A priority Critical patent/EP3725888A1/en Publication of EP3725888A1 publication Critical patent/EP3725888A1/en Status Pending legal-status Critical Current Links Original Assignee Targovax ASA Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Inventor Lukasz KURYK Jon Amund Eriksen Peter SKORPIL Robert Burns Anne-Sophie MØLLER Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Pending Application number EP19169841.4A Other languages German ( de)

#Snapgene p2a pdf#

Google Patents Oncolytic adenoviral vector expressing peptidylarginine deiminase and tissue inhibitor of metalloproteinaseĭownload PDF Info Publication number EP3725888A1 EP3725888A1 EP19169841.4A EP19169841A EP3725888A1 EP 3725888 A1 EP3725888 A1 EP 3725888A1 EP 19169841 A EP19169841 A EP 19169841A EP 3725888 A1 EP3725888 A1 EP 3725888A1 Authority EP European Patent Office Prior art keywords cancer adenoviral vector tgx cell timp Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.

Google Patents EP3725888A1 - Oncolytic adenoviral vector expressing peptidylarginine deiminase and tissue inhibitor of metalloproteinase EP3725888A1 - Oncolytic adenoviral vector expressing peptidylarginine deiminase and tissue inhibitor of metalloproteinase